Comparative expression profile of miRNA and mRNA In primary peripheral blood mononuclear cells infected with human immunodeficiency virus (HIV-1)

PLoS ONE

Volumn 6, Issue 7, 2011, Pages

  Gupta, Ankit ^a   Nagilla, Pruthvi ^a   Le, Hai Son ^b   Bunney, Coulton ^a   Zych, Courtney ^a   Thalamuthu, Anbupalam ^c   Bar Joseph, Ziv ^b   Mathavan, Sinnakaruppan ^c   Ayyavoo, Velpandi ^a  

^a UNIVERSITY OF PITTSBURGH GRADUATE SCHOOL OF PUBLIC HEALTH   (United States)

^b Carnegie Mellon University   (United States)

^c GENOME INSTITUTE OF SINGAPORE   (Singapore)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CELL CYCLE; CELL DIFFERENTIATION; CELL PROLIFERATION; CONTROLLED STUDY; CYTOKINE RESPONSE; DOWN REGULATION; GENE CONTROL; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; IMMUNE RESPONSE; MICROARRAY ANALYSIS; PERIPHERAL BLOOD MONONUCLEAR CELL; QUANTITATIVE ANALYSIS; SIGNAL TRANSDUCTION; T LYMPHOCYTE; TRANSCRIPTION REGULATION; UPREGULATION; VIRUS CELL INTERACTION; VIRUS INFECTIVITY; COMPARATIVE STUDY; DNA MICROARRAY; GENETICS; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; METABOLISM; MONONUCLEAR CELL; PHYSIOLOGY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; VIROLOGY;

HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1;

MESSENGER RNA; MICRORNA; TUMOR MARKER;

GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; HIV INFECTIONS; HIV-1; HUMANS; LEUKOCYTES, MONONUCLEAR; MICRORNAS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SIGNAL TRANSDUCTION; TUMOR MARKERS, BIOLOGICAL;

EID: 79960883949     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0022730     Document Type: Article

References (81)

1. Li Q, Smith AJ, Schacker TW, Carlis JV, Duan L, et al. (2009) Microarray analysis of lymphatic tissue reveals stage-specific, gene expression signatures in HIV-1 infection. J Immunol 183: 1975-1982.
2. Wu JQ, Dwyer DE, Dyer WB, Yang YH, Wang B, et al. (2008) Transcriptional profiles in CD8+ T cells from HIV+ progressors on HAART are characterized by coordinated up-regulation of oxidative phosphorylation enzymes and interferon responses. Virology 380: 124-135.
3. van 't Wout AB, Lehrman GK, Mikheeva SA, O'Keeffe GC, Katze MG, et al. (2003) Cellular gene expression upon human immunodeficiency virus type 1 infection of CD4(+)-T-cell lines. J Virol 77: 1392-1402.
4. Garcia-Arriaza J, Najera JL, Gomez CE, Sorzano CO, Esteban M, (2010) Immunogenic profiling in mice of a HIV/AIDS vaccine candidate (MVA-B) expressing four HIV-1 antigens and potentiation by specific gene deletions. PLoS One 5: e12395.
5. van 't Wout AB, Swain JV, Schindler M, Rao U, Pathmajeyan MS, et al. (2005) Nef induces multiple genes involved in cholesterol synthesis and uptake in human immunodeficiency virus type 1-infected T cells. J Virol 79: 10053-10058.
6. Zaunders J, Dyer WB, Churchill M, (2011) The Sydney Blood Bank Cohort: implications for viral fitness as a cause of elite control. Curr Opin HIV AIDS 6: 151-156.
7. Herbeck JT, Gottlieb GS, Winkler CA, Nelson GW, An P, et al. (2010) Multistage genomewide association study identifies a locus at 1q41 associated with rate of HIV-1 disease progression to clinical AIDS. J Infect Dis 201: 618-626.
8. McMichael AJ, Jones EY, (2010) Genetics. First-class control of HIV-1. Science 330: 1488-1490.
9. Limou S, Le Clerc S, Coulonges C, Carpentier W, Dina C, et al. (2009) Genomewide association study of an AIDS-nonprogression cohort emphasizes the role played by HLA genes (ANRS Genomewide Association Study 02). J Infect Dis 199: 419-426.
10. Smith MW, Dean M, Carrington M, Winkler C, Huttley GA, et al. (1997) Contrasting genetic influence of CCR2 and CCR5 variants on HIV-1 infection and disease progression. Hemophilia Growth and Development Study (HGDS), Multicenter AIDS Cohort Study (MACS), Multicenter Hemophilia Cohort Study (MHCS), San Francisco City Cohort (SFCC), ALIVE Study. Science 277: 959-965.
11. Dragic T, Litwin V, Allaway GP, Martin SR, Huang Y, et al. (1996) HIV-1 entry into CD4+ cells is mediated by the chemokine receptor CC-CKR-5. Nature 381: 667-673.
12. Hladik F, Liu H, Speelmon E, Livingston-Rosanoff D, Wilson S, et al. (2005) Combined effect of CCR5-Delta32 heterozygosity and the CCR5 promoter polymorphism-2459 A/G on CCR5 expression and resistance to human immunodeficiency virus type 1 transmission. J Virol 79: 11677-11684.
13. Mummidi S, Ahuja SS, Gonzalez E, Anderson SA, Santiago EN, et al. (1998) Genealogy of the CCR5 locus and chemokine system gene variants associated with altered rates of HIV-1 disease progression. Nat Med 4: 786-793.
14. O'Brien SJ, Nelson GW, (2004) Human genes that limit AIDS. Nature Genetics 36: 565-574.
15. Jeannet M, Sztajzel R, Carpentier N, Hirschel B, Tiercy JM, (1989) HLA antigens are risk factors for development of AIDS. J Acquir Immune Defic Syndr 2: 28-32.
16. Nieto G, Barber Y, Rubio MC, Rubio M, Fibla J, (2004) Association between AIDS disease progression rates and the Fok-I polymorphism of the VDR gene in a cohort of HIV-1 seropositive patients. J Steroid Biochem Mol Biol 89-90: 199-207.
17. Paxton WA, Kang S, (1998) Chemokine receptor allelic polymorphisms: relationships to HIV resistance and disease progression. Semin Immunol 10: 187-194.
18. Ballana E, Senserrich J, Pauls E, Faner R, Mercader JM, et al. (2010) ZNRD1 (zinc ribbon domain-containing 1) is a host cellular factor that influences HIV-1 replication and disease progression. Clin Infect Dis 50: 1022-1032.
19. Ciccosanti F, Corazzari M, Soldani F, Matarrese P, Pagliarini V, et al. Proteomic analysis identifies prohibitin down-regulation as a crucial event in the mitochondrial damage observed in HIV-infected patients. Antivir Ther 15: 377-390.
20. Melendez LM, Colon K, Rivera L, Rodriguez-Franco E, Toro-Nieves D, Proteomic analysis of HIV-infected macrophages. J Neuroimmune Pharmacol 6: 89-106.
21. Ringrose JH, Jeeninga RE, Berkhout B, Speijer D, (2008) Proteomic studies reveal coordinated changes in T-cell expression patterns upon infection with human immunodeficiency virus type 1. J Virol 82: 4320-4330.
22. Zhang L, Jia X, Zhang X, Sun J, Peng X, et al. Proteomic analysis of PBMCs: characterization of potential HIV-associated proteins. Proteome Sci 8: 12.
23. Geiss GK, Bumgarner RE, An MC, Agy MB, van 't Wout AB, et al. (2000) Large-scale monitoring of host cell gene expression during HIV-1 infection using cDNA microarrays. Virology 266: 8-16.
24. Ryo A, Suzuki Y, Arai M, Kondoh N, Wakatsuki T, et al. (2000) Identification and characterization of differentially expressed mRNAs in HIV type 1-infected human T cells. AIDS Res Hum Retroviruses 16: 995-1005.
25. Vahey MT, Nau ME, Jagodzinski LL, Yalley-Ogunro J, Taubman M, et al. (2002) Impact of viral infection on the gene expression profiles of proliferating normal human peripheral blood mononuclear cells infected with HIV type 1 RF. AIDS Res Hum Retroviruses 18: 179-192.
26. Burgener A, Sainsbury J, Plummer FA, Ball TB, Systems biology-based approaches to understand HIV-exposed uninfected women. Curr HIV/AIDS Rep 7: 53-59.
27. Hirbod T, Nilsson J, Andersson S, Uberti-Foppa C, Ferrari D, et al. (2006) Upregulation of interferon-alpha and RANTES in the cervix of HIV-1-seronegative women with high-risk behavior. J Acquir Immune Defic Syndr 43: 137-143.
28. Mothe B, Ibarrondo J, Llano A, Brander C, (2009) Virological, immune and host genetics markers in the control of HIV infection. Dis Markers 27: 105-120.
29. Charurat M, Blattner W, Hershow R, Buck A, Zorrilla CD, et al. (2004) Changing trends in clinical AIDS presentations and survival among HIV-1-infected women. J Womens Health (Larchmt) 13: 719-730.
30. Poropatich K, Sullivan DJ Jr, (2011) Human immunodeficiency virus type 1 long-term non-progressors: the viral, genetic and immunological basis for disease non-progression. J Gen Virol 92: 247-268.
31. Barnes MR, Deharo S, Grocock RJ, Brown JR, Sanseau P, (2007) The micro RNA target paradigm: a fundamental and polymorphic control layer of cellular expression. Expert Opin Biol Ther 7: 1387-1399.
32. Carthew RW, Sontheimer EJ, (2009) Origins and Mechanisms of miRNAs and siRNAs. Cell 136: 642-655.
33. Chua JH, Armugam A, Jeyaseelan K, (2009) MicroRNAs: biogenesis, function and applications. Curr Opin Mol Ther 11: 189-199.
34. Alvarez-Garcia I, Miska EA, (2005) MicroRNA functions in animal development and human disease. Development 132: 4653-4662.
35. Chang TC, Mendell JT, (2007) microRNAs in vertebrate physiology and human disease. Annu Rev Genomics Hum Genet 8: 215-239.
36. Baltimore D, Boldin MP, O'Connell RM, Rao DS, Taganov KD, (2008) MicroRNAs: new regulators of immune cell development and function. Nat Immunol 9: 839-845.
37. Barik S, (2005) Silence of the transcripts: RNA interference in medicine. J Mol Med 83: 764-773.
38. Amariglio N, Rechavi G, (2007) A-to-I RNA editing: a new regulatory mechanism of global gene expression. Blood Cells Mol Dis 39: 151-155.
39. Gomase VS, Parundekar AN, (2009) microRNA: human disease and development. Int J Bioinform Res Appl 5: 479-500.
40. Fritz JH, Girardin SE, Philpott DJ, (2006) Innate immune defense through RNA interference. Sci STKE.
41. Carissimi C, Fulci V, Macino G, (2009) MicroRNAs: novel regulators of immunity. Autoimmun Rev 8: 520-524.
42. O'Connell RM, Rao DS, Chaudhuri AA, Baltimore D, (2010) Physiological and pathological roles for microRNAs in the immune system. Nat Rev Immunol 10: 111-122.
43. Wang X, Ye L, Hou W, Zhou Y, Wang YJ, et al. (2009) Cellular microRNA expression correlates with susceptibility of monocytes/macrophages to HIV-1 infection. Blood 113: 671-674.
44. Houzet L, Yeung ML, de Lame V, Desai D, Smith SM, et al. (2008) MicroRNA profile changes in human immunodeficiency virus type 1 (HIV-1) seropositive individuals. Retrovirology 5: 118.
45. Van den Bergh R, Florence E, Vlieghe E, Boonefaes T, Grooten J, et al. (2010) Transcriptome analysis of monocyte-HIV interactions. Retrovirology 7: 53.
46. Rotger M, Dang KK, Fellay J, Heinzen EL, Feng S, et al. (2010) Genome-wide mRNA expression correlates of viral control in CD4+ T-cells from HIV-1-infected individuals. PLoS Pathog 6: e1000781.
47. Majumder B, Janket ML, Schafer EA, Schaubert K, Huang XL, et al. (2005) Human immunodeficiency virus type 1 Vpr impairs dendritic cell maturation and T-cell activation: implications for viral immune escape. J Virol 79: 7990-8003.
48. Venkatachari NJ, Buchanan WG, Ayyavoo V, (2008) Human immunodeficiency virus (HIV-1) infection selectively downregulates PD-1 expression in infected cells and protects the cells from early apoptosis in vitro and in vivo. Virology 376: 140-153.
49. Huang JC, Morris QD, Frey BJ, (2007) Bayesian inference of MicroRNA targets from sequence and expression data. J Comput Biol 14: 550-563.
50. Griffiths-Jones S, Saini HK, van Dongen S, Enright AJ, (2008) miRBase: tools for microRNA genomics. Nucleic Acids Res 36: D154-158.
51. Tusher VG, Tibshirani R, Chu G, (2001) Significance analysis of microarrays applied to the ionizing radiation response. Proc Natl Acad Sci U S A 98: 5116-5121.
52. Weber J, Rangel HR, Chakraborty B, Tadele M, Martinez MA, et al. (2003) A novel TaqMan real-time PCR assay to estimate ex vivo human immunodeficiency virus type 1 fitness in the era of multi-target (pol and env) antiretroviral therapy. J Gen Virol 84: 2217-2228.
53. Asmuth DM, Wang N, Lu Y, Li XD, Reece L, et al. (2005) Cell cycle kinetic dysregulation in HIV-infected normal lymphocytes. Cytometry A 66: 41-51.
54. Chan EY, Qian WJ, Diamond DL, Liu T, Gritsenko MA, et al. (2007) Quantitative analysis of human immunodeficiency virus type 1-infected CD4+ cell proteome: dysregulated cell cycle progression and nuclear transport coincide with robust virus production. J Virol 81: 7571-7583.
55. Backes C, Meese E, Lenhof HP, Keller A, (2010) A dictionary on microRNAs and their putative target pathways. Nucleic Acids Res 38: 4476-4486.
56. Bartel DP, (2009) MicroRNAs: target recognition and regulatory functions. Cell 136: 215-233.
57. Shalgi R, Lieber D, Oren M, Pilpel Y, (2007) Global and local architecture of the mammalian microRNA-transcription factor regulatory network. PLoS Comput Biol 3: e131.
58. Sundaravaradan V, Mehta R, Harris DT, Zack JA, Ahmad N, Differential expression and interaction of host factors augment HIV-1 gene expression in neonatal mononuclear cells. Virology 400: 32-43.
59. Brown JN, Kohler JJ, Coberley CR, Sleasman JW, Goodenow MM, (2008) HIV-1 activates macrophages independent of Toll-like receptors. PLoS One 3: e3664.
60. Xing HQ, Hayakawa H, Izumo K, Kubota R, Gelpi E, et al. (2009) In vivo expression of proinflammatory cytokines in HIV encephalitis: an analysis of 11 autopsy cases. Neuropathology 29: 433-442.
61. Borjabad A, Brooks AI, Volsky DJ, (2009) Gene expression profiles of HIV-1-infected glia and brain: toward better understanding of the role of astrocytes in HIV-1-associated neurocognitive disorders. J Neuroimmune Pharmacol 5: 44-62.
62. Li Y, Chan EY, Katze MG, (2007) Functional genomics analyses of differential macaque peripheral blood mononuclear cell infections by human immunodeficiency virus-1 and simian immunodeficiency virus. Virology 366: 137-149.
63. Noorbakhsh F, Ramachandran R, Barsby N, Ellestad KK, LeBlanc A, et al. (2010) MicroRNA profiling reveals new aspects of HIV neurodegeneration: caspase-6 regulates astrocyte survival. FASEB J 24: 1799-1812.
64. Tatro ET, Scott ER, Nguyen TB, Salaria S, Banerjee S, et al. Evidence for Alteration of Gene Regulatory Networks through MicroRNAs of the HIV-infected brain: novel analysis of retrospective cases. PLoS One 5: e10337.
65. Zhao X, He X, Han X, Yu Y, Ye F, et al. (2010) MicroRNA-mediated control of oligodendrocyte differentiation. Neuron 65: 612-626.
66. Lagos-Quintana M, Rauhut R, Yalcin A, Meyer J, Lendeckel W, et al. (2002) Identification of tissue-specific microRNAs from mouse. Curr Biol 12: 735-739.
67. Liu X, Wang T, Wakita T, Yang W, (2010) Systematic identification of microRNA and messenger RNA profiles in hepatitis C virus-infected human hepatoma cells. Virology 398: 57-67.
68. Lee JE, Nam HY, Shim SM, Bae GR, Han BG, et al. (2010) Expression phenotype changes of EBV-transformed lymphoblastoid cell lines during long-term subculture and its clinical significance. Cell Prolif 43: 378-384.
69. Imig J, Motsch N, Zhu JY, Barth S, Okoniewski M, et al. (2010) microRNA profiling in Epstein-Barr virus-associated B-cell lymphoma. Nucleic Acids Res 39: 1880-1893.
70. Li LM, Hu ZB, Zhou ZX, Chen X, Liu FY, et al. (2010) Serum microRNA profiles serve as novel biomarkers for HBV infection and diagnosis of HBV-positive hepatocarcinoma. Cancer Res 70: 9798-9807.
71. Wu H, Neilson JR, Kumar P, Manocha M, Shankar P, et al. (2007) miRNA profiling of naive, effector and memory CD8 T cells. PLoS One 2: e1020.
72. Kaul D, Ahlawat A, Gupta SD, (2009) HIV-1 genome-encoded hiv1-mir-H1 impairs cellular responses to infection. Mol Cell Biochem 323: 143-148.
73. Klase Z, Winograd R, Davis J, Carpio L, Hildreth R, et al. (2009) HIV-1 TAR miRNA protects against apoptosis by altering cellular gene expression. Retrovirology 6: 18.
74. Narayanan A, Kehn-Hall K, Bailey C, Kashanchi F, (2010) Analysis of the roles of HIV-derived microRNAs. Expert Opin Biol Ther 11: 17-29.
75. Zhang C, (2009) Novel functions for small RNA molecules. Curr Opin Mol Ther 11: 641-651.
76. Fabian MR, Sundermeier TR, Sonenberg N, (2009) Understanding how miRNAs post-transcriptionally regulate gene expression. Prog Mol Subcell Biol 50: 1-20.
77. Fabian MR, Sonenberg N, Filipowicz W, (2010) Regulation of mRNA translation and stability by microRNAs. Annu Rev Biochem 79: 351-379.
78. Huang J, Liang Z, Yang B, Tian H, Ma J, et al. (2007) Derepression of microRNA-mediated protein translation inhibition by apolipoprotein B mRNA-editing enzyme catalytic polypeptide-like 3G (APOBEC3G) and its family members. J Biol Chem 282: 33632-33640.
79. Huntzinger E, Izaurralde E, Gene silencing by microRNAs: contributions of translational repression and mRNA decay. Nat Rev Genet 12: 99-110.
80. Sung TL, Rice AP, (2009) miR-198 inhibits HIV-1 gene expression and replication in monocytes and its mechanism of action appears to involve repression of cyclin T1. PLoS Pathog 5: e1000263.
81. Imig J, Motsch N, Zhu JY, Barth S, Okoniewski M, et al. (2010) microRNA profiling in Epstein-Barr virus-associated B-cell lymphoma. Nucleic Acids Res.